Vlad Coric Revance Therapeutics, Inc. (RVNC) insider trading activity

RVNC Quotes by TradingView

Vlad Coric is Director of Revance Therapeutics, Inc.. Currently has a direct ownership of 20,784 shares of RVNC, which is worth approximately $53,414. The most recent transaction as insider was on May 01, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.8K
0% 3M change
259.34% 12M change
Total Value Held $53,414

Vlad Coric Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 41.92%
20,784 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
589 Added 9.24%
5,784 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
5,195 Added 50.0%
5,195 Common Stock

Also insider at

BHVN
Biohaven Pharmaceutical Holding Co Ltd. Healthcare
Chief Executive Officer
BHVN
Biohaven Ltd.
Chief Executive Officer
VC

Vlad Coric

Director
New Haven, CT

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVNC